Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PARADIGM

Financiado

Cerrado

Patients Active in Research and Dialogues for an Improved Generation of Medicine...

Patients Active in Research and Dialogues for an Improved Generation of Medicines Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGM will provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engagement (PE) and demonstrates the ‘return on the engagement’ for all players. Much needed pro... ver más

30/11/2020

EUROPEAN PATIENTS...

9M€

Presupuesto del proyecto: 9M€

Líder del proyecto

FORUM DES PATIENTS EUROPEENS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 37 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-11-30

IMI2-2016-10-07: Patient perspectives in medicines l...

I+D

Cerrada hace 7 años

0% 49% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

37 Participantes

EUROPEAN PATIENTS FORUM

702.52K€ | Lider

ALLEA

90.63K€ | Participante

Instituto Aragonés de Cienci...

181.09K€ | Participante

IRIS

413.27K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PATIENTPARTNER Identifying the Needs for Patients Partnering in Clinical Re... 1M€ Cerrado

RESPECT Relating Expectations and needs to Participation and Empower... 560K€ Cerrado

MEDUNIVERSE SCALING UP OF THE MEDUNIVERSE PATIENT CASE ENGAGEMENT PLATFO... 71K€ Cerrado

SHARE4RARE Social media platform dedicated to rare diseases using coll... 2M€ Cerrado

H2O H2O Health Outcomes Observatory 22M€ Cerrado

IMA-cRCT Effectiveness and cost effectiveness of the Initial Medicati... 1M€ Cerrado

Duración del proyecto: 29 meses Fecha Inicio: 2018-06-04
Fecha Fin: 2020-11-30

Líder del proyecto

FORUM DES PATIENTS EUROPEENS No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 9M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto PARADIGM will provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engagement (PE) and demonstrates the ‘return on the engagement’ for all players. Much needed processes and tools for three key decision-making points (research priority setting, design of clinical trials and early dialogue) will be developed by consensus. Building on advances at international level, PARADIGM will integrate the needs, perspectives and expectations of all actors (including vulnerable populations) involved and will also produce a stakeholder-tailored set of metrics to measure the impact of PE. PARADIGM will deliver to the community, recommendations and tools to support the implementation of PE, leveraging pre-existing resources. These will address capacity and capability questions, managing potential conflict of interest, the compensation of individuals and organisations, and the ethics of engagement. A targeted communication, dissemination and engagement strategy will promote the endorsement of the outputs for their integration in existing structures. PARADIGM will develop a strategy for sustaining the long-term implementation of PE resources aimed at structuring and supporting the community. This will be a game-changer, addressing fundamental gaps and creating real assets to ensure the sustainability of the PE ecosystem in the years to come. PARADIGM has a common vision and values-base, and is a highly innovative, consensus-oriented, and experienced consortium, comprising pan-European leaders in patient engagement, academia, SMEs, health professionals, pharmaceutical and biotech companies, pharmaceutical corporate associations, and representatives of competent authorities, all bringing complementary know-how to partner with industry, and a strong commitment to transform patient engagement in Europe.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores